 |
|
|
| |
Effects of direct-acting antivirals on end-stage liver disease and mortality among Florida Medicaid beneficiaries with chronic hepatitis C: 31% with cirrhosis received DAA, 12% without cirrhosis 2013-2019
|
| |
| |
EASL 2024 June 5-8 Milan Italy
Pei-Lin Huang1, Shao-Hsuan Chang1, Roniel Cabrera2, Debbie Wilson1, Haesuk Park1
1University of Florida College of Pharmacy, Gainesville, United States, 2University of Florida College of Medicine, Gainesville, United States
Method: We conducted a retrospective cohort study of 2013-2019 Florida Medicaid data of beneficiaries aged 18-64 years with a diagnosis with hepatitis C (HCV).
|
| |
|
|
|
|
|
